awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q42856089-FD8F62FA-5DB6-423D-8E01-A116340B5A64
Q42856089-FD8F62FA-5DB6-423D-8E01-A116340B5A64
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42856089-FD8F62FA-5DB6-423D-8E01-A116340B5A64
Sorafenib improves rituximab and ofatumumab efficacy by decreasing the expression of complement regulatory proteins
P2860
Q42856089-FD8F62FA-5DB6-423D-8E01-A116340B5A64
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42856089-FD8F62FA-5DB6-423D-8E01-A116340B5A64
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
adb984ad89be48da73cb9bacc2a9dcfcf66a8b77
P2860
STAT3 targets suggest mechanisms of aggressive tumorigenesis in diffuse large B-cell lymphoma.